type 2 diabetes

Boston Therapeutics Inc reports topline U.S.-based phase IIb study results of BTI-320 in patients with type 2 diabetes
Reuters
Thu, 10/9/14 - 10:54 am
Boston Therapeutics
type 2 diabetes
BTI-320
Vivus announces journal publication of Qsymia study results in type 2 diabetes
Seeking Alpha
Mon, 10/6/14 - 11:06 am
Vivus
Qsymia
type 2 diabetes
MannKind and Sanofi Complete Afrezza Collaboration Deal
Yahoo/Zacks
Sat, 09/27/14 - 10:11 am
MannKind
Sanofi
Afrezza
diabetes
type 2 diabetes
Who Will Win This $45 Billion Market?
Motley Fool
Sat, 06/21/14 - 11:45 am
Sanofi
Novo Nordisk
diabetes
type 1 diabetes
type 2 diabetes
Eli Lilly/ Boehringer Drug Under FDA Review
Yahoo/Zacks.com
Tue, 04/15/14 - 04:49 pm
FDA
Eli Lilly
Boehringer Ingelheim
Trajenta
empagliflozin
diabetes
type 2 diabetes
FDA approves Tanzeum to treat type 2 diabetes
Yahoo/Fly on the Wall
Tue, 04/15/14 - 10:34 am
FDA
Tanzeum
type 2 diabetes
diabetes
thyroid cancer
GSK
FDA staff review raises questions about MannKind diabetes device
Yahoo/Reuters
Sat, 03/29/14 - 09:13 am
MannKind
diabetes
type 2 diabetes
Type 2 Diabetes Gene Mutations Seen as Drugmaker Target
Bloomberg
Mon, 03/3/14 - 08:30 am
diabetes
type 2 diabetes
Pfizer
GlaxoSmithKline's Eperzan Gets Closer to Launch
Motley Fool
Sun, 01/26/14 - 10:53 am
GSK
Eperzan
diabetes
type 2 diabetes
Arena Eyes Additional Opportunity With Belviq
Seeking Alpha
Sat, 12/7/13 - 12:50 pm
Arena Pharmaceuticals
Belviq
smoking cessation
type 2 diabetes
Diabetes battle "being lost" as cases hit record 382 mln
Yahoo/Reuters
Thu, 11/14/13 - 10:36 am
diabetes
China
type 2 diabetes
Bristol-Myers: Interesting Investing Opportunity With Onglyza
Seeking Alpha
Sat, 09/28/13 - 12:15 pm
type 2 diabetes
Onglyza
diabetes
Bristol-Myers Squibb
AstraZeneca
Groundbreaking Diabetes Drug Headlines Approval Bonanza
Motley Fool
Sun, 09/22/13 - 11:25 am
diabetes
type 2 diabetes
type 1 diabetes
JNJ
inokana
Forxiga
AstraZeneca
Bristol-Myers Squibb
3 Drug Classes That May Become Obsolete Within 3 Years
Motley Fool
Sun, 09/15/13 - 12:26 pm
interferon
hepatitis C
type 2 diabetes
dialysis
Is This Diabetes Drug Stock in Jeopardy?
Motley Fool
Sun, 09/15/13 - 12:25 pm
Novo Nordisk
Victoza
diabetes
type 2 diabetes
Lixisenatide NDA Withdrawn by Sanofi
Yahoo/Zacks
Sat, 09/14/13 - 10:52 am
lixisenatide
Sanofi
type 2 diabetes
diabetes
A Closer Look at 3 Players in Diabetes Treatments
Motley Fool
Sat, 08/17/13 - 10:55 am
type 2 diabetes
type 1 diabetes
Osiris Therapeutics
MannKind
diabetes
NovoNordisk
Positive Data on MannKind's Afrezza
Yahoo/Zacks
Sat, 08/17/13 - 10:38 am
MannKind
diabetes
Afrezza
type 2 diabetes
GlaxoSmithKline diabetes drug faces U.S. approval delay
Reuters
Sat, 08/3/13 - 10:11 am
albiglutide
type 2 diabetes
diabetes
Are These Diabetes Drugs Safe After All?
Motley Fool
Thu, 08/1/13 - 09:17 am
Januvia
Merck
Byetta
Bristol-Myers Squibb
diabetes
type 2 diabetes

Pages